This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Metabolix's CEO Discusses Business Update (Transcript)

Metabolix, Inc. ( MBLX)

Business Update Conference Call

January 12, 2012 5:00 pm ET

Executives

James Palczynski – ICR, Investor Relations

Richard P. Eno – President and Chief Executive Officer

Joseph D. Hill – Chief Financial Officer

Oliver P. Peoples – Co-Founder, Chief Scientific Officer

Analysts

JinMing Liu – Ardour Capital Investments

Jeff Zekauskas – JPMorgan Securities, Inc.

Jeff Osborne – Stifel Nicolaus

Laurence Alexander – Jefferies & Co.

Presentation

Operator

Good afternoon, ladies and gentlemen, welcome to the Metabolix Incorporated business update conference call. As a reminder, today’s call is being recorded.

I would now like to turn the conference over to Mr. James Palczynski of ICR. Please go ahead.

James Palczynski

Thank you, operator, and good afternoon, everyone. Metabolix issued a press release after the market closed today. If you do not have a copy, one may be found on the website at www.metabolix.com in the Investor Relations section. Making the presentation today will be Richard Eno, President and Chief Executive Officer of Metabolix; and Joseph Hill, Chief Financial Officer of the Company. They are joined by Oliver Peoples, a Co-founder of Metabolix and Chief Scientific Officer.

Before we begin our formal remarks, I need to remind everyone that, part of our discussion today will include forward-looking statements. These statements are not guarantees of future performance, and therefore, undue reliance should not be put upon them. The Company undertakes no obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this conference call.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,047.81 -22.59 -0.12%
S&P 500 2,113.16 -1.33 -0.06%
NASDAQ 5,003.0120 -13.9170 -0.28%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs